Emmanuel Njeuhmeli1, Marjorie Opuni2, Melissa Schnure3, Michel Tchuenche4, Peter Stegman4, Elizabeth Gold5, Valerian Kiggundu1, Nida Parks1, Kim Seifert Ahanda1, Maria Carrasco1,6, Katharine Kripke4. 1. Office of HIV/AIDS, Global Health Bureau, United States Agency for International Development, Washington, District of Columbia. 2. Independent Consultant, Geneva, Switzerland. 3. Palladium Group, Washington, District of Columbia. 4. Avenir Health, Washington, District of Columbia. 5. Johns Hopkins Center for Communication Programs, Baltimore, Maryland. 6. Department of Health, Behavior and Society, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
Abstract
Background: The new World Health Organization and Joint United Nations Programme on HIV/AIDS strategic framework for voluntary medical male circumcision (VMMC) aims to increase VMMC coverage among males aged 10-29 years in priority settings to 90% by 2021. We use mathematical modeling to assess the likelihood that selected countries will achieve this objective, given their historical VMMC progress and current implementation options. Methods: We use the Decision Makers' Program Planning Toolkit, version 2, to examine 4 ambitious but feasible scenarios for scaling up VMMC coverage from 2017 through 2021, inclusive in Lesotho, Malawi, Mozambique, Namibia, South Africa, Swaziland, Tanzania, Uganda, and Zimbabwe. Results: Tanzania is the only country that would reach the goal of 90% VMMC coverage in 10- to 29-year-olds by the end of 2021 in the scenarios assessed, and this was true in 3 of the scenarios studied. Mozambique, South Africa, and Lesotho would come close to reaching the objective only in the most ambitious scenario examined. Conclusions: Major changes in VMMC implementation in most countries will be required to increase the proportion of circumcised 10- to 29-year-olds to 90% by the end of 2021. Scaling up VMMC coverage in males aged 10-29 years will require significantly increasing the number of circumcisions provided to 10- to 14-year-olds and 15- to 29-year-olds.
Background: The new World Health Organization and Joint United Nations Programme on HIV/AIDS strategic framework for voluntary medical male circumcision (VMMC) aims to increase VMMC coverage among males aged 10-29 years in priority settings to 90% by 2021. We use mathematical modeling to assess the likelihood that selected countries will achieve this objective, given their historical VMMC progress and current implementation options. Methods: We use the Decision Makers' Program Planning Toolkit, version 2, to examine 4 ambitious but feasible scenarios for scaling up VMMC coverage from 2017 through 2021, inclusive in Lesotho, Malawi, Mozambique, Namibia, South Africa, Swaziland, Tanzania, Uganda, and Zimbabwe. Results: Tanzania is the only country that would reach the goal of 90% VMMC coverage in 10- to 29-year-olds by the end of 2021 in the scenarios assessed, and this was true in 3 of the scenarios studied. Mozambique, South Africa, and Lesotho would come close to reaching the objective only in the most ambitious scenario examined. Conclusions: Major changes in VMMC implementation in most countries will be required to increase the proportion of circumcised 10- to 29-year-olds to 90% by the end of 2021. Scaling up VMMC coverage in males aged 10-29 years will require significantly increasing the number of circumcisions provided to 10- to 14-year-olds and 15- to 29-year-olds.
Authors: Eshan U Patel; Michelle R Kaufman; Kim H Dam; Lynn M Van Lith; Karin Hatzold; Arik V Marcell; Webster Mavhu; Catherine Kahabuka; Lusanda Mahlasela; Emmanuel Njeuhmeli; Kim Seifert Ahanda; Getrude Ncube; Gissenge Lija; Collen Bonnecwe; Aaron A R Tobian Journal: Clin Infect Dis Date: 2018-04-03 Impact factor: 9.079
Authors: Caryl Feldacker; Isaac Holeman; Vernon Murenje; Sinokuthemba Xaba; Michael Korir; Bill Wambua; Batsirai Makunike-Chikwinya; Marrianne Holec; Scott Barnhart; Mufuta Tshimanga Journal: PLoS One Date: 2020-06-16 Impact factor: 3.240
Authors: Joseph B Babigumira; Scott Barnhart; Joanna M Mendelsohn; Vernon Murenje; Mufuta Tshimanga; Christina Mauhy; Isaac Holeman; Sinokuthemba Xaba; Marrianne M Holec; Batsirai Makunike-Chikwinya; Caryl Feldacker Journal: PLoS One Date: 2020-09-30 Impact factor: 3.240
Authors: Webster Mavhu; Melissa Neuman; Karin Hatzold; Stephen Buzuzi; Galven Maringwa; Sungai T Chabata; Collin Mangenah; Noah Taruberekera; Ngonidzashe Madidi; Malvern Munjoma; Getrude Ncube; Sinokuthemba Xaba; Owen Mugurungi; Cheryl C Johnson; Elizabeth L Corbett; Helen A Weiss; Katherine Fielding; Frances M Cowan Journal: BMJ Glob Health Date: 2021-07